CORT
Corcept Therapeutics Incorporated$46.73+0.51 (+1.10%)Prev Close$46.22·MCap$4.90B·P/E56.22·Vol468.0K·Yield—
▲
Buys (12M)
1
$3.31M
▼
Sells (12M)
65
$97.89M
◆
Net Activity
Net Seller
$94.58M
●
Active Insiders
11
last 12 mo
Over the past 12 months, insider activity at Corcept Therapeutics Incorporated (CORT) has been dominated by selling, with 1 insider purchase totaling $3.31M and 65 insider sales totaling $97.89M. The most recent insider transaction was by Guyer William (officer: Chief Development Officer), who sold $819.4K worth of shares on Apr 8, 2026. Corcept Therapeutics Incorporated operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $4.90B.
CORT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.97 | $819.4K | 2,231-90% |
| Mar 27, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 26,198 | $50.07 | $1.31M | 2,918,326 |
| Mar 24, 2026 | Guyer William | officer: Chief Development Officer | Sell | 11,767 | $36.01 | $423.7K | 2,231-84% |
| Mar 19, 2026 | BAKER G LEONARD JR | director | Buy | 100,000 | $33.14 | $3.31M | 1,146,631 |
| Mar 6, 2026 | Guyer William | officer: Chief Development Officer | Sell | 8,233 | $35.99 | $296.3K | 2,231-79% |
| Feb 9, 2026 | Hunt Hazel | Chief Scientific Officer | Sell | 77,968 | $41.31 | $3.22M | 0 |
| Feb 5, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 1,235-94% |
| Feb 3, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 0 |
| Jan 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 1,235-94% |
| Jan 6, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 0 |
| Dec 24, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 306,846 | $83.59 | $25.65M | 0 |
| Dec 24, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 80,284 | $83.59 | $6.71M | 0 |
| Dec 1, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $79.77 | $3.19M | 0 |
| Dec 1, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $80.08 | $1.60M | 0 |
| Dec 1, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,110 | $79.53 | $406.4K | 0 |
| Dec 1, 2025 | Maduck Sean | See Remarks | Sell | 20,135 | $79.53 | $1.60M | 0 |
| Dec 1, 2025 | Mokari Atabak | Chief Financial Officer | Sell | 118 | $79.78 | $9.4K | 0 |
| Dec 1, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 148 | $79.78 | $11.8K | 0 |
| Nov 25, 2025 | Guyer William | Chief Development Officer | Sell | 4,500 | $80.90 | $364.1K | 0 |
| Nov 5, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $75.36 | $1.51M | 0 |
| Nov 3, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $74.58 | $2.98M | 0 |
| Nov 3, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $73.65 | $368.2K | 0 |
| Nov 3, 2025 | Maduck Sean | See Remarks | Sell | 20,000 | $73.99 | $1.48M | 0 |
| Oct 10, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $87.54 | $192.6K | 0 |
| Oct 7, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $89.94 | $1.80M | 0 |
| Oct 1, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $85.08 | $3.40M | 0 |
| Oct 1, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $84.75 | $423.8K | 0 |
| Oct 1, 2025 | Maduck Sean | See Remarks | Sell | 20,000 | $85.06 | $1.70M | 0 |
| Sep 10, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $72.45 | $159.4K | 0 |
| Sep 4, 2025 | Cannon Gillian | Director | Sell | 3,607 | $70.13 | $253.0K | 0 |
| Sep 2, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $70.53 | $2.82M | 0 |
| Sep 2, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $70.49 | $1.41M | 0 |
| Sep 2, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,189 | $70.29 | $364.7K | 0 |
| Sep 2, 2025 | Maduck Sean | See Remarks | Sell | 20,233 | $70.50 | $1.43M | 0 |
| Sep 2, 2025 | Mokari Atabak | Chief Financial Officer | Sell | 144 | $71.38 | $10.3K | 0 |
| Sep 2, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 256 | $71.38 | $18.3K | 0 |
| Aug 22, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 5,000 | $71.22 | $356.1K | 0 |
| Aug 11, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $72.30 | $159.1K | 0 |
| Aug 8, 2025 | Guyer William | Chief Development Officer | Sell | 35,007 | $71.77 | $2.51M | 0 |
| Aug 5, 2025 | Guyer William | Chief Development Officer | Sell | 14 | $71.77 | $1.0K | 0 |
| Aug 1, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $68.53 | $2.74M | 0 |
| Aug 1, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,823 | $67.51 | $393.1K | 0 |
| Jul 17, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 615 | $73.69 | $45.3K | 0 |
| Jul 17, 2025 | Guyer William | Chief Development Officer | Sell | 4,879 | $73.48 | $358.5K | 0 |
| Jul 17, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 4,077 | $73.47 | $299.5K | 0 |
| Jul 17, 2025 | Maduck Sean | See Remarks | Sell | 4,788 | $73.47 | $351.8K | 0 |
| Jul 10, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $71.08 | $156.4K | 0 |
| Jul 1, 2025 | Guyer William | Chief Development Officer | Sell | 100 | $73.51 | $7.4K | 0 |
| Jul 1, 2025 | Maduck Sean | See Remarks | Sell | 205 | $73.45 | $15.1K | 0 |
| Jun 16, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 3,185 | $70.77 | $225.4K | 0 |
Showing 1–50 of 185
1 / 4
CORT Insider Buying Activity
The following table shows recent insider purchases of Corcept Therapeutics Incorporated (CORT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | BAKER G LEONARD JR | director | Buy | 100,000 | $33.14 | $3.31M | 1,146,631 |
CORT Insider Selling Activity
The following table shows recent insider sales of Corcept Therapeutics Incorporated (CORT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.97 | $819.4K | 2,231-90% |
| Mar 27, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 26,198 | $50.07 | $1.31M | 2,918,326 |
| Mar 24, 2026 | Guyer William | officer: Chief Development Officer | Sell | 11,767 | $36.01 | $423.7K | 2,231-84% |
| Mar 6, 2026 | Guyer William | officer: Chief Development Officer | Sell | 8,233 | $35.99 | $296.3K | 2,231-79% |
| Feb 9, 2026 | Hunt Hazel | Chief Scientific Officer | Sell | 77,968 | $41.31 | $3.22M | 0 |
| Feb 5, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 1,235-94% |
| Feb 3, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 0 |
| Jan 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 1,235-94% |
| Jan 6, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 0 |
| Dec 24, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 306,846 | $83.59 | $25.65M | 0 |
| Dec 24, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 80,284 | $83.59 | $6.71M | 0 |
| Dec 1, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $79.77 | $3.19M | 0 |
| Dec 1, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $80.08 | $1.60M | 0 |
| Dec 1, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,110 | $79.53 | $406.4K | 0 |
| Dec 1, 2025 | Maduck Sean | See Remarks | Sell | 20,135 | $79.53 | $1.60M | 0 |
| Dec 1, 2025 | Mokari Atabak | Chief Financial Officer | Sell | 118 | $79.78 | $9.4K | 0 |
| Dec 1, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 148 | $79.78 | $11.8K | 0 |
| Nov 25, 2025 | Guyer William | Chief Development Officer | Sell | 4,500 | $80.90 | $364.1K | 0 |
| Nov 5, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $75.36 | $1.51M | 0 |
| Nov 3, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $74.58 | $2.98M | 0 |
| Nov 3, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $73.65 | $368.2K | 0 |
| Nov 3, 2025 | Maduck Sean | See Remarks | Sell | 20,000 | $73.99 | $1.48M | 0 |
| Oct 10, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $87.54 | $192.6K | 0 |
| Oct 7, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $89.94 | $1.80M | 0 |
| Oct 1, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $85.08 | $3.40M | 0 |
| Oct 1, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $84.75 | $423.8K | 0 |
| Oct 1, 2025 | Maduck Sean | See Remarks | Sell | 20,000 | $85.06 | $1.70M | 0 |
| Sep 10, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $72.45 | $159.4K | 0 |
| Sep 4, 2025 | Cannon Gillian | Director | Sell | 3,607 | $70.13 | $253.0K | 0 |
| Sep 2, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $70.53 | $2.82M | 0 |
| Sep 2, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $70.49 | $1.41M | 0 |
| Sep 2, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,189 | $70.29 | $364.7K | 0 |
| Sep 2, 2025 | Maduck Sean | See Remarks | Sell | 20,233 | $70.50 | $1.43M | 0 |
| Sep 2, 2025 | Mokari Atabak | Chief Financial Officer | Sell | 144 | $71.38 | $10.3K | 0 |
| Sep 2, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 256 | $71.38 | $18.3K | 0 |
| Aug 22, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 5,000 | $71.22 | $356.1K | 0 |
| Aug 11, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $72.30 | $159.1K | 0 |
| Aug 8, 2025 | Guyer William | Chief Development Officer | Sell | 35,007 | $71.77 | $2.51M | 0 |
| Aug 5, 2025 | Guyer William | Chief Development Officer | Sell | 14 | $71.77 | $1.0K | 0 |
| Aug 1, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $68.53 | $2.74M | 0 |
| Aug 1, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,823 | $67.51 | $393.1K | 0 |
| Jul 17, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 615 | $73.69 | $45.3K | 0 |
| Jul 17, 2025 | Guyer William | Chief Development Officer | Sell | 4,879 | $73.48 | $358.5K | 0 |
| Jul 17, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 4,077 | $73.47 | $299.5K | 0 |
| Jul 17, 2025 | Maduck Sean | See Remarks | Sell | 4,788 | $73.47 | $351.8K | 0 |
| Jul 10, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $71.08 | $156.4K | 0 |
| Jul 1, 2025 | Guyer William | Chief Development Officer | Sell | 100 | $73.51 | $7.4K | 0 |
| Jul 1, 2025 | Maduck Sean | See Remarks | Sell | 205 | $73.45 | $15.1K | 0 |
| Jun 16, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 3,185 | $70.77 | $225.4K | 0 |
CORT Insiders
Similar Stocks to CORT
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B